GSK Can Tweak COVID Vaccine UPC Claim Against Moderna
The Unified Patent Court has allowed GlaxoSmithKline to amend its infringement claim to include the latest version of Moderna's COVID-19 vaccine, ruling that the U.K. pharmaceuticals giant's new arguments simply build...To view the full article, register now.
Already a subscriber? Click here to view full article